Indogulf Cropsciences balance sheet

As of Mar 2026

Total assets: ₹823cr+19.7% on Mar 2025
Shareholders' equity: ₹459cr+66.9% on Mar 2025
Total debt: ₹177cr−22.0% on Mar 2025
Cash and investments: ₹12.3cr+27.1% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025

Non-current assets
	36.2	36.0
	76.4	57.1
	11.4	11.4
	1.0	0.9
	11.6	0.0
	1.0	0.7
	12.7	0.7
	20.2	10.2
	158	116
Current assets
	343	270
	241	223
	12.3	9.7
	0.7	5.0
	254	238
	67.8	51.3
	665	571
	0.8	0.8
	823	688
Equity
	63.2	48.8
	396	226
	459	275
	459	275
Liabilities
	3.0	40.0
	12.7	8.5
	15.6	48.5
	4.2	2.4
	−3.4	−2.5
	16.4	48.4
	174	187
	128	134
	29.2	26.1
	331	347
	1.7	1.0
	12.8	13.5
	2.1	2.7
	348	364
	364	413
	823	688
Assets — additional as-filed lines
	0.0	11.8
Trade payables — MSME split
	12.4	11.8
	115	123

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

IGCL₹58.41

Indogulf Cropsciences Limited

· Chemicals

₹ CrorePeersBESTAGRO HERANBA ADVANCE DHARMAJ ASTEC PUNJABCHEM MOL IPLMcap ₹369 Cr

View

In ₹ Crore except Per Share As of	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	36.0	36.2	36.2
+ Capital Work-in-Progress	57.1	76.4	76.4
+ Other Intangibles	11.4	11.4	11.4
+ Intangibles under Development	0.9	1.0	1.0
+ Non-current Investments	0.0	11.6	11.6
+ Other Non-current Financial Assets	0.7	1.0	1.0
Non-current Financial Assets	0.7	12.7	12.7
+ Other Non-current Assets	10.2	20.2	20.2
Total Non-current Assets	116.4	157.8	157.8
Current Assets
+ Inventories	270.0	343.5	343.5
+ Trade Receivables	223.0	240.6	240.6
+ Cash & Cash Equivalents	9.7	12.3	12.3
+ Other Current Financial Assets	5.0	0.7	0.7
Current Financial Assets	237.6	253.5	253.5
+ Other Current Assets	51.3	67.8	67.8
Total Current Assets	570.7	664.8	664.8
+ Assets Held for Sale	0.8	0.8	0.8
Total Assets	687.9	823.4	823.4
Equity
+ Equity Share Capital	48.8	63.2	63.2
+ Other Equity / Reserves	226.5	396.1	396.1
Equity — Owners of Parent	275.3	459.3	459.3
Total Equity	275.3	459.3	459.3
Liabilities
+ Borrowings — Non-current	40.0	3.0	3.0
+ Other Non-current Financial Liab	8.5	12.7	12.7
Non-current Financial Liabilities	48.5	15.6	15.6
+ Provisions — Non-current	2.4	4.2	4.2
+ Deferred Tax Liabilities	-2.5	-3.4	-3.4
Non-current Liabilities	48.4	16.4	16.4
+ Borrowings — Current	186.7	173.9	173.9
+ Trade Payables	134.3	127.9	127.9
+ Other Current Financial Liab	26.1	29.2	29.2
Current Financial Liabilities	347.1	331.0	331.0
+ Provisions — Current	1.0	1.7	1.7
+ Current Tax Liabilities	13.5	12.8	12.8
+ Other Current Liabilities	2.7	2.1	2.1
Current Liabilities	364.2	347.6	347.6
Total Liabilities	412.6	364.0	364.0
Total Equity & Liabilities	687.9	823.4	823.4
Assets — additional as-filed lines
+ Current Tax Assets	11.8	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	11.8	12.4	12.4
+ Dues to Other Creditors — Current	122.5	115.4	115.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.